<p>This project involves the fabrication and testing of microporous, polymer membranes designed to remove minute amounts of toxic air pollutants such as formaldehyde from air streams. The hypothesis to be tested is that active, the silver contained within the porous polymer membranes results in high formaldehyde retention.</p><p>Monolayers consist of different sizes of sPS particles are assembled first on the silicon wafers by spin coating method and convective assembly method, respectively. Then each kind of monolayer with one dimension of sPS particles is deposited with a nanometer scaled silver thin film with a bench top metal evaporator. The porous membranes are produced by assembly of close-packed colloidal crystals of silver capped polystyrene template particles and subsequent infiltration with polyurethane prepolymer. The prepolymer is cured by UV exposure. The sPS particles are removed from the particle polymer membrane by treatment with organic solvents resulting in the formation of inverse opal structures. Silver does not dissolve in the organic solvents and cannot leave the pores due to the small size of connecting holes in an inverse opal. All the monolayers, cylindrical colloidal crystals and microcapillaries after infiltration of polyurethane had been characterized by optical microscope, and the porous membranes had been characterized by SEM.</p><p>The application of porous membranes with silver caps is to absorb formaldehyde in the air, while in fact the silver caps are oxidized and become Ag2O, which will initiate a gas-phase/solid reaction with formaldehyde. In the future, TiO2 will be applied together with Ag2O, since TiO2 is another good absorbent for formaldehyde</p>

Protein biomarkers are important diagnostic tools for detection of non-communicable diseases, such as cancer and cardiovascular conditions. In order to be used as diagnostic tools they need to be detected at very low concentrations in biological samples (e.g. whole blood, serum or urine). This has been currently performed in central laboratories using expensive, bulky equipment and time consuming assays.

This project involves the fabrication and testing of microporous, polymer membranes designed to remove minute amounts of toxic air pollutants such as formaldehyde from air streams. The hypothesis to be tested is that active, the silver contained within the porous polymer membranes results in high formaldehyde retention. Monolayers consist of different sizes of sPS particles are assembled first on the silicon wafers by spin coating method and convective assembly method, respectively. Then each kind of monolayer with one dimension of sPS particles is deposited with a nanometer scaled silver thin film with a bench top metal evaporator. The porous membranes are produced by assembly of close-packed colloidal crystals of silver capped polystyrene template particles and subsequent infiltration with polyurethane prepolymer. The prepolymer is cured by UV exposure. The sPS particles are removed from the particle polymer membrane by treatment with organic solvents resulting in the formation of inverse opal structures. Silver does not dissolve in the organic solvents and cannot leave the pores due to the small size of connecting holes in an inverse opal. All the monolayers, cylindrical colloidal crystals and microcapillaries after infiltration of polyurethane had been characterized by optical microscope, and the porous membranes had been characterized by SEM. The application of porous membranes with silver caps is to absorb formaldehyde in the air, while in fact the silver caps are oxidized and become Ag2O, which will initiate a gas-phase/solid reaction with formaldehyde. In the future, TiO2 will be applied together with Ag2O, since TiO2 is another good absorbent for formaldehyde

One of the greatest obstacles to clinical translation of bone tissue engineering is the inability to effectively and efficiently vascularise scaffolds. This limits the size of defects that can be repaired, as blood perfusion is necessary to provide nutrient and waste exchange to tissue at the core of scaffolds. The goal of this work was to systematically explore whether architecture, at a scale of hundreds of microns, can be used to direct the growth of microvessels into the core of scaffolds. A pipeline was developed for the production of hydroxyapatite surfaces with controlled architecture. Three batches of hydroxyapatite were used with two different particle morphologies and size distributions. On sintering, one batch remained phase pure and the other two batches were biphasic mixtures of α-tricalcium phosphate (α-TCP) and hydroxyapatite. Sample production methods based on slip casting of a hydroxyapatite-gelatin slurry were explored. The most successful of these involved the use of curable silicone to produce moulds of high-resolution, three dimensional (3D) printed parts with the desired design. Parts were dried and sintered to produce patterned surfaces with higher resolution than obtainable through conventional 3D printing techniques. Given the difficulties associated with the structural reproducibility of concave pores architectures in 3D reported in the literature, in this work, a 2.5D model has been developed that varies architectural parameters in a controlled manner. Six contrasting architectures consisting of semi-circular ridges and grooves were produced. Grooves and ridges were designed to have widths of 330 μm and 660 μm, with periodicities, respectively, of 1240 μm and 630 μm. Groove depth was varied between 150 μm and 585 μm. Co-cultures of endothelial cells and osteoblasts were optimised and used to grow microcapillary-like structures (referred to as "microvessels") on substrates. Literature shows that these precursors to microcapillaries contain lumina and can produce functional vasculature, demonstrating their clinical promise. The effects of the composition and surface texture of grooved samples on microvessel formation were studied. It was found that surface microtopography and phase purity (α-TCP content) did not affect microvessel formation. However, hydroxyapatite architecture was found to significantly affect microvessel location and orientation. Microvessels were found to form predominantly in grooves or between convexities. Two metrics - the degree of alignment (DOA) and the degree of containment (DOC) - were developed to measure the alignment of endothelial cell structures and their localisation in grooves. For all patterned samples, the CD31 (an endothelial cell marker) signal was at least 2.5 times higher along grooves versus perpendicular to grooves. In addition, the average signal was at least two times higher within grooves than outside grooves for all samples. Small deep grooves had the highest DOA and DOC (6.13 and 4.05 respectively), and individual, highly aligned microvessels were formed. An image analysis method that compares sample X-ray microtomography sections to original designs to quantify architectural distortion was developed. This method will serve as a useful tool for improvements to architectural control for future studies. This body of work shows the crucial influence of architecture on microvessel self-assembly at the hundreds of micron scale. It also highlights that microvessel formation has a relatively low sensitivity to phase composition and microtopography. These findings have important implications for the design of porous scaffolds and the refinement of fabrication technologies. While important results were shown for six preliminary architectures, this work represents a toolkit that can be applied to screen any 2.5D architecture for its angiogenic potential. This work has laid the foundations that will allow elucidating the precise correspondence between architecture and microvessel organisation, ultimately enabling the "engineering" of microvasculature by tuning local scaffold design to achieve desirable microvessel properties.